MDCG Guidance on Breakthrough Devices under the MDR and the IVDR
Medical Devices, In vitro diagnostic Medical Devices Elisabethann Wright Medical Devices, In vitro diagnostic Medical Devices Elisabethann Wright

MDCG Guidance on Breakthrough Devices under the MDR and the IVDR

The Medical Device Coordination Group (MDCG) has published its Guidance, MDCG 2025-9, on Breakthrough Devices within the Medical Devices Regulation (MDR) and the in vitro diagnostics Medical Devices Regulation (IVDR).

Neither the MDR nor the IVDR include a definition of what constitutes a Breakthrough Device. MDCG 2026-9, however,

Read More
MDCG Guidance on post-market surveillance of Medical Devices and In Vitro Diagnostic Medical Devices

MDCG Guidance on post-market surveillance of Medical Devices and In Vitro Diagnostic Medical Devices

In its last publication of 2025, MDCG 2025-10, the Medical Device Coordination Group (MDCG) provides guidance to manufacturers concerning the post-market surveillance (PMS) obligations imposed by the Medical Devices Regulation (MDR) and the in vitro diagnostics Medical Devices Regulation (IVDR) and the appropriate steps to ensure that these are fulfilled.

The Guidance recalls

Read More
MDGC Publishes Guidance on Performance Studies for IVDs

MDGC Publishes Guidance on Performance Studies for IVDs

The Medical Devices (Post-market Surveillance Requirements) (Amendment) (Great Britain) Regulations 2024 entered into force on 16 June 2024. The Regulations, which apply in Great Britain, introduce a new Part 4A to the existing Regulations governing post-market surveillance (PMS) requirements for medical devices. These include in vitro diagnostic (IVD) devices and active implantable medical devices.

Read More
New MHRA Guidance concerning extended periods of validity of CE Certificates and Declarations of Conformity for some in vitro diagnostic medical devices
MHRA, Single Use, In vitro diagnostic Medical Devices Elisabethann Wright MHRA, Single Use, In vitro diagnostic Medical Devices Elisabethann Wright

New MHRA Guidance concerning extended periods of validity of CE Certificates and Declarations of Conformity for some in vitro diagnostic medical devices

Reflecting the 2024 revisions to the EU in vitro diagnostic Medical Devices Regulation, the UK MHRA has published a legislation extending acceptance of CE-marked in vitro diagnostic medical devices (IVDs) on the Great Britain (GB) market (Registration of certain in vitro diagnostic devices - GOV.UK).

Read More